In addition, it is worth noting that due to the COVID-19 pandemic, our study also suggests that breast cancer patients may exhibit higher ACE2 expression after chemotherapy, which increases the risk of infection with SARS-CoV-2 and contributes to high COVID-19 mortality in cancer patients [60]. This evidence concerns the gene ACE2 and cancer.